Literature DB >> 26559841

Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.

Natalie N Kinloch1, Daniel R MacMillan1, Anh Q Le1, Laura A Cotton1, David R Bangsberg2, Susan Buchbinder3, Mary Carrington4, Jonathan Fuchs3, P Richard Harrigan5, Beryl Koblin6, Margot Kushel7, Martin Markowitz8, Kenneth Mayer9, M J Milloy5, Martin T Schechter10, Theresa Wagner11, Bruce D Walker12, Jonathan M Carlson13, Art F Y Poon14, Zabrina L Brumme15.   

Abstract

UNLABELLED: Human leukocyte antigen (HLA) class I-associated polymorphisms in HIV-1 that persist upon transmission to HLA-mismatched hosts may spread in the population as the epidemic progresses. Transmission of HIV-1 sequences containing such adaptations may undermine cellular immune responses to the incoming virus in future hosts. Building upon previous work, we investigated the extent of HLA-associated polymorphism accumulation in HIV-1 polymerase (Pol) through comparative analysis of linked HIV-1/HLA class I genotypes sampled during historic (1979 to 1989; n = 338) and modern (2001 to 2011; n = 278) eras from across North America (Vancouver, BC, Canada; Boston, MA; New York, NY; and San Francisco, CA). Phylogenies inferred from historic and modern HIV-1 Pol sequences were star-like in shape, with an inferred most recent common ancestor (epidemic founder virus) sequence nearly identical to the modern North American subtype B consensus sequence. Nevertheless, modern HIV-1 Pol sequences exhibited roughly 2-fold-higher patristic (tip-to-tip) genetic distances than historic sequences, with HLA pressures likely driving ongoing diversification. Moreover, the frequencies of published HLA-associated polymorphisms in individuals lacking the selecting HLA class I allele was on average ∼2.5-fold higher in the modern than in the historic era, supporting their spread in circulation, though some remained stable in frequency during this time. Notably, polymorphisms restricted by protective HLA alleles appear to be spreading to a greater relative extent than others, though these increases are generally of modest absolute magnitude. However, despite evidence of polymorphism spread, North American hosts generally remain at relatively low risk of acquiring an HIV-1 polymerase sequence substantially preadapted to their HLA profiles, even in the present era. IMPORTANCE: HLA class I-restricted cytotoxic T-lymphocyte (CTL) escape mutations in HIV-1 that persist upon transmission may accumulate in circulation over time, potentially undermining host antiviral immunity to the transmitted viral strain. We studied >600 experimentally collected HIV-1 polymerase sequences linked to host HLA information dating back to 1979, along with phylogenetically reconstructed HIV-1 sequences dating back to the virus' introduction into North America. Overall, our results support the gradual spread of many-though not all-HIV-1 polymerase immune escape mutations in circulation over time. This is consistent with recent observations from other global regions, though the extent of polymorphism accumulation in North America appears to be lower than in populations with high seroprevalence, older epidemics, and/or limited HLA diversity. Importantly, the risk of acquiring an HIV-1 polymerase sequence at transmission that is substantially preadapted to one's HLA profile remains relatively low in North America, even in the present era.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26559841      PMCID: PMC4719594          DOI: 10.1128/JVI.02353-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

1.  Founder effects in the assessment of HIV polymorphisms and HLA allele associations.

Authors:  Tanmoy Bhattacharya; Marcus Daniels; David Heckerman; Brian Foley; Nicole Frahm; Carl Kadie; Jonathan Carlson; Karina Yusim; Ben McMahon; Brian Gaschen; Simon Mallal; James I Mullins; David C Nickle; Joshua Herbeck; Christine Rousseau; Gerald H Learn; Toshiyuki Miura; Christian Brander; Bruce Walker; Bette Korber
Journal:  Science       Date:  2007-03-16       Impact factor: 47.728

2.  Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution.

Authors:  Bin Li; Adrianne D Gladden; Marcus Altfeld; John M Kaldor; David A Cooper; Anthony D Kelleher; Todd M Allen
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

3.  The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody.

Authors:  E Jeffries; B Willoughby; W J Boyko; M T Schechter; B Wiggs; S Fay; M O'Shaughnessy
Journal:  Can Med Assoc J       Date:  1985-06-15       Impact factor: 8.262

4.  HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently.

Authors:  Emma L Turnbull; A Ross Lopes; Nicola A Jones; David Cornforth; Phillipa Newton; Diana Aldam; Pierre Pellegrino; Jo Turner; Ian Williams; Craig M Wilson; Paul A Goepfert; Mala K Maini; Persephone Borrow
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

5.  Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.

Authors:  Mark A Brockman; Arne Schneidewind; Matthew Lahaie; Aaron Schmidt; Toshiyuki Miura; Ivna Desouza; Faina Ryvkin; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Joseph Mulenga; Paul A Goepfert; Bruce D Walker; Todd M Allen
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

6.  Frequent transmission of cytotoxic-T-lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population.

Authors:  Tae Furutsuki; Noriaki Hosoya; Ai Kawana-Tachikawa; Mariko Tomizawa; Takashi Odawara; Mieko Goto; Yoshihiro Kitamura; Tetsuya Nakamura; Anthony D Kelleher; David A Cooper; Aikichi Iwamoto
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  The Vancouver Lymphadenopathy-AIDS Study: 1. Persistent generalized lymphadenopathy.

Authors:  M T Schechter; W J Boyko; E Jeffries; B Willoughby; R Nitz; P Constance
Journal:  Can Med Assoc J       Date:  1985-06-01       Impact factor: 8.262

8.  Maternal versus paternal inheritance of HLA class I alleles among HIV-infected children: consequences for clinical disease progression.

Authors:  Louise Kuhn; Elaine J Abrams; Paul Palumbo; Marc Bulterys; Ronnie Aga; Leslie Louie; Thomas Hodge
Journal:  AIDS       Date:  2004-06-18       Impact factor: 4.177

Review 9.  Is HIV-1 evolving to a less virulent form in humans?

Authors:  Kevin K Ariën; Guido Vanham; Eric J Arts
Journal:  Nat Rev Microbiol       Date:  2007-01-04       Impact factor: 60.633

10.  Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.

Authors:  Javier Martinez-Picado; Julia G Prado; Elizabeth E Fry; Katja Pfafferott; Alasdair Leslie; Senica Chetty; Christina Thobakgale; Isobel Honeyborne; Hayley Crawford; Philippa Matthews; Tilly Pillay; Christine Rousseau; James I Mullins; Christian Brander; Bruce D Walker; David I Stuart; Photini Kiepiela; Philip Goulder
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more
  7 in total

Review 1.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

2.  Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico.

Authors:  Maribel Soto-Nava; Santiago Avila-Ríos; Humberto Valenzuela-Ponce; Claudia García-Morales; Jonathan M Carlson; Daniela Tapia-Trejo; Daniela Garrido-Rodriguez; Selma N Alva-Hernández; Thalía A García-Tellez; Akio Murakami-Ogasawara; Simon A Mallal; Mina John; Mark A Brockman; Chanson J Brumme; Zabrina L Brumme; Gustavo Reyes-Teran
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

3.  T-cell responses to sequentially emerging viral escape mutants shape long-term HIV-1 population dynamics.

Authors:  Tomohiro Akahoshi; Hiroyuki Gatanaga; Nozomi Kuse; Takayuki Chikata; Madoka Koyanagi; Naoki Ishizuka; Chanson J Brumme; Hayato Murakoshi; Zabrina L Brumme; Shinichi Oka; Masafumi Takiguchi
Journal:  PLoS Pathog       Date:  2020-12-28       Impact factor: 6.823

4.  HIV-1 p24Gag adaptation to modern and archaic HLA-allele frequency differences in ethnic groups contributes to viral subtype diversification.

Authors:  Nicolaas C Kist; Ben Lambert; Samuel Campbell; Aris Katzourakis; Daniel Lunn; Philippe Lemey; Astrid K N Iversen
Journal:  Virus Evol       Date:  2020-12-12

5.  Extensive host immune adaptation in a concentrated North American HIV epidemic.

Authors:  Zabrina L Brumme; Natalie N Kinloch; Stephen Sanche; Alexander Wong; Eric Martin; Kyle D Cobarrubias; Paul Sandstrom; Paul N Levett; P Richard Harrigan; Jeffrey B Joy
Journal:  AIDS       Date:  2018-09-10       Impact factor: 4.177

6.  Genetic divergence of HIV-1 B subtype in Italy over the years 2003-2016 and impact on CTL escape prevalence.

Authors:  Claudia Alteri; Lavinia Fabeni; Rossana Scutari; Giulia Berno; Domenico Di Carlo; Caterina Gori; Ada Bertoli; Alessandra Vergori; Ilaria Mastrorosa; Rita Bellagamba; Cristina Mussini; Manuela Colafigli; Francesco Montella; Alfredo Pennica; Claudio Maria Mastroianni; Enrico Girardi; Massimo Andreoni; Andrea Antinori; Valentina Svicher; Francesca Ceccherini-Silberstein; Carlo Federico Perno; Maria Mercedes Santoro
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

7.  Evidence for a recombinant origin of HIV-1 Group M from genomic variation.

Authors:  Abayomi S Olabode; Mariano Avino; Garway T Ng; Faisal Abu-Sardanah; David W Dick; Art F Y Poon
Journal:  Virus Evol       Date:  2019-01-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.